Manufacturing Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing Pharmaceutical TechnologyWhen Eli Lilly's Lebanon campus is complete, it will manufacture several of the pharma's APIs and genetic medicines to serve US patients.Read full story pharminent May 7, 2026 (Last updated: May 8, 2026) Pharmaceutical Technology When Eli Lilly’s Lebanon campus is complete, it will manufacture several of the pharma’s APIs and genetic medicines to serve US patients. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Daiichi Sankyo and Waiv partner for ADC biomarkersNext: UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies Related Stories Manufacturing FDA Warning Letter Hits Sanofi’s Genzyme Ireland Site pharminent July 8, 2026 Manufacturing Tanabe pens deal to sell plants to Towa in post-buyout pivot pharminent July 8, 2026 Manufacturing FDA Selects Seven for PreCheck Pilot to Advance Drug Manufacturing pharminent July 1, 2026
